Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00835 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Mikhail Matveyenka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Peptide Fragments, Microglia, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
- Department of Biology, Belarussian State University, Minsk 220030, Belarus.
ORCID-Profile: Dmitry Kurouski
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Matveyenka, M., Sholukh, M., & Kurouski, D. (2025). Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00835
Vancouver
Matveyenka M, Sholukh M, Kurouski D. Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00835
BibTeX
@article{Matveyenka2025,
author = {Matveyenka, Mikhail and Sholukh, Mikhail and Kurouski, Dmitry},
title = {Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00835}
}
EUVIMED